Recombinant Human RPS3A Protein, N-His

Title: Introduction to Recombinant Human RPS3A Protein

Recombinant Human RPS3A Protein, also known as ribosomal protein S3A, is a highly conserved protein that plays a crucial role in protein synthesis. It is a member of the small ribosomal subunit and is involved in the binding of mRNA and tRNA during translation. In recent years, this protein has gained significant attention in the scientific community due to its potential applications in various fields, including medicine and biotechnology. In this article, we will explore the structure, activity, and applications of Recombinant Human RPS3A Protein.

Title: Structure of Recombinant Human RPS3A Protein

The Recombinant Human RPS3A Protein is composed of 246 amino acids with a molecular weight of approximately 28 kDa. It has a characteristic beta-barrel structure with a globular N-terminal domain and an extended C-terminal domain. The N-terminal domain contains a highly conserved RNA-binding motif, while the C-terminal domain is involved in protein-protein interactions. The protein also has two zinc-binding domains, which are essential for its structural stability and function.

Title: Activity of Recombinant Human RPS3A Protein

The primary function of Recombinant Human RPS3A Protein is to bind to the 3′ untranslated region (UTR) of mRNA and facilitate the recruitment of the small ribosomal subunit during translation. It also plays a crucial role in the initiation and elongation phases of protein synthesis. Additionally, this protein has been shown to interact with various other cellular proteins, including transcription factors and DNA repair enzymes, indicating its involvement in other cellular processes.

Title: Applications of Recombinant Human RPS3A Protein

Recombinant Human RPS3A Protein has a wide range of applications in both basic research and industrial settings. One of the main applications of this protein is in the production of recombinant proteins. As it is a critical component of the translation machinery, it can be used to optimize protein expression in various expression systems. It has also been utilized in the development of novel protein production platforms, such as cell-free protein synthesis systems.

In the field of medicine, Recombinant Human RPS3A Protein has shown promise as a potential therapeutic target for various diseases. Studies have demonstrated its role in cancer progression and metastasis, making it a potential target for cancer treatment. Additionally, this protein has been linked to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, and could be a potential target for drug development.

Title: Recombinant Human RPS3A Protein as an Antigen

Recombinant Human RPS3A Protein has also been used as an antigen in various immunological studies. It has been shown to induce a strong immune response in animal models, making it a potential candidate for vaccine development. It has also been used as a diagnostic tool for certain autoimmune diseases, where antibodies against this protein have been detected in patient samples.

Title: Conclusion

In conclusion, Recombinant Human RPS3A Protein is a highly conserved protein with a crucial role in protein synthesis. Its unique structure and diverse functions make it a valuable tool for various applications, including protein production, drug development, and immunological studies. Further research on this protein could lead to a better understanding of its role in various cellular processes and potential therapeutic interventions.

ProteoGenix catalogue number ARO-P11832. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 26.45 kDa; Fragment: Ser26-Gly233; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet